Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2019-08-21 Proxy Solicitation & In…
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Notice of General Meeting/Proxy Form 15 pages 558.0KB
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'Notice of General Meeting' and includes details such as the venue, date, time, agenda, resolutions to be voted on, proxy instructions, and an explanatory statement. It discusses shareholder voting on ratification of prior share issues under listing rules, details of share placements, and related corporate actions. The content is typical of materials sent to shareholders to inform them about an upcoming general meeting and to solicit their votes on specific resolutions. There is no financial data, earnings information, or detailed management discussion. The document is not a report itself but a notice and explanatory statement for a shareholder meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI).
2019-08-21 English
Cancellation of Blockshine Health JV Agreement 2 pages 347.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX Market Announcement dated 6 August 2019 from Genetic Technologies Limited. It provides an update on the cancellation of a Joint Venture Agreement and discusses the breach of ASX Listing Rule 10.1.4 related to shareholder approval. The document is relatively short (4120 characters) and focuses on a specific corporate event and regulatory compliance issue rather than presenting financial data or detailed reports. There is no indication of financial statements, earnings data, or comprehensive management discussion. The content is an announcement about a corporate action and regulatory compliance, fitting best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2019-08-05 English
Operational Update - Blockchain Activities 2 pages 337.2KB
Capital/Financing Update Classification · 90% confidence The document is an ASX Market Announcement providing an operational update specifically about the company's blockchain activities, including details about agreements, joint ventures, and future intentions. It does not contain financial statements, earnings data, or detailed management analysis. It is not a report but an update announcement. The content focuses on strategic and operational developments rather than financial results or governance changes. Therefore, it fits best under Capital/Financing Update (CAP) as it discusses strategic alliances and share issuance conditions related to blockchain projects, which are financing-related updates.
2019-08-05 English
Reinstatement to Official Quotation 1 page 216.3KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX regarding the reinstatement to official quotation of Genetic Technologies Limited's securities after a suspension. It mentions a breach of Chapter 10 of the Listing Rules but does not contain financial data, detailed reports, or management commentary. The document is short (671 characters) and serves as a regulatory announcement about trading status rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-08-05 English
Suspension from Official Quotation 1 page 217.0KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from ASX regarding the suspension of Genetic Technologies Limited's securities from official quotation due to a breach of listing rules. It is a regulatory announcement about trading status, not a financial report, management change, or other specific filing. The document is short and serves as a formal notice. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement.
2019-08-01 English
Quarterly Update and 4C 10 pages 362.5KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 June 2019.' It contains detailed operational highlights, management changes, product development updates, and a comprehensive Appendix 4C which is a quarterly report including cash flow statements and financial data. The presence of substantive financial data and analysis for a quarter, along with operational and strategic updates, clearly identifies this as a quarterly report. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q4 2019
2019-07-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.